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ABSTRACT 
Entering entrepreneurship is known to be a demanding activity with increased workload, financial 
uncertainty and increased levels of stress. Despite this knowledge, there are no systematic studies on 
how entrepreneurship affects the people involved. The authors investigate prescriptions of 
psychotropics for 12,412 entrepreneurs and their 5,007 spouses in the first year after becoming 
entrepreneurs in a matched case-control study. The entrepreneurs become entrepreneurs from 1999-
2001 and their use of psychotropics is studied in the year after. The authors find that entrepreneurs 
founding business with no employees have higher likelihood of receiving prescriptions for 
antidepressants compared to their control group of non-entrepreneurs (odds ratio 1.23 [95% CI: 1.07-
1.46], P=0.024). Entrepreneurs founding larger business with more employees (only 10% of all 
entrepreneurs) are less likely to receive antidepressants (0.41 [95% CI: 0.23-0.75], P=0.024). The 
authors find that spouses of these entrepreneurs are more likely to get prescriptions for antidepressants 
(1.40 [95% CI: 1.06-1.85], P=0.019) and hypnotics/anxiolytics (1.40 [95% CI: 1.04-1.86], P=0.024). 
This study shows that there is a significant connection between entering entrepreneurship and 
receiving psychotropics. It shows that the spouses of entrepreneurs are even more likely to receive this 
medication than the entrepreneurs themselves, emphasizing that entrepreneurship potentially have 
negative consequences.  
 
 
Medical Subject Headings 
Anxiety Disorders [F03.080], Depressive Disorder [F03.600.300], Entrepreneurship [J01.219.375], 
Mental Health [F02.418], Sleep Disorders [F03.870], Sociology [I01.880] 
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MOTIVATION 
Western world economies are relying heavily on continuous entry into entrepreneurship to secure the 
future welfare of their populations. This strategy involves numerous initiatives to increase the number 
of entrepreneurs. However, given that entrepreneurship is a difficult and complex task, this strategy 
could involve negative consequences. 
 
Prevalence of persons entering entrepreneurship is around 2-4 % every year (1). Often entering 
entrepreneurship means leaving a secure wage-work for a risk-bearing future where the family’s future 
economic well-being could be on the line (2). In addition, entering entrepreneurship is associated with 
severe risk factors, e.g. increased workload, divorce rate, financial risk and increased level of stress (3-
5). Around 40 % of new companies will close within the first year and 60 % within five years which 
makes the life of new entrepreneurs challenging (6-8). Especially, the first years of entrepreneurship 
are associated with these challenging factors because it takes time for new businesses to adapt to 
business life and for entrepreneurs and their relatives to adapt to a new way of living. Failure can have 
severe personal and financial consequences because entrepreneurs often have invested a significant 
amount of the family’s financial resources in the firm.   
 
Changes in the work organization, e.g. downsizing or expanding, have been associated with an impact 
on the health of employees (9-11). Kivimäki et al. found that downsizing was correlated with an 
increased use of psychotropics among the employees remaining in the companies downsizing (9). The 
health of new entrepreneurs is important because proper health monitoring and guidance on 
entrepreneurship might increase the chances of survival for the company and decrease the negative 
impact on the lives of the entrepreneurs and their relatives. Especially in smaller companies family 
members often help or support financially which also make them prone to stress and mental health 
problems (5).  
 
Common symptoms of stress are insomnia, tiredness, pain, depression and stomach problems (12;13). 
Stress leads to activation of the hypothalamus-pituitary-adrenal axis (HPA) and as consequence 
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depression might occur (14). Work stress have also been found to increase the risk of depression (15). 
Furthermore, increased workload has been associated with increased prescription of antidepressants 
(16). 
 
However, after searching the Medline database the authors did not find any studies investigating how 
entering entrepreneurship affects the health of entrepreneurs and their relatives measured by the 
prescription of psychotropics. The authors examined the use of psychotropics on an individual level 
for entrepreneurs and their relatives the first two years after entering entrepreneurship by using data 
from government prescription and labor market databases. 
 
METHODS 
Participants 
Use of psychotropics was mapped using the Danish Prescription Database, administered by Statistics 
Denmark and controlled by the Danish Medicines Agency. This database contains all drug 
prescriptions in Denmark from 1995 to 2003. Each prescription is listed with patient ID and contains 
information on volume and type of drug. Prescription data were linked with data from the Integrated 
Database for Labor Market Research (IDA) and the Entrepreneurship database.  
 
The IDA database contains combined information on every person and firm in Denmark from 1980 to 
2003 gathered from the official registers of the Danish government, which, because of its extensive 
welfare policies, records extremely detailed information on the population. The Entrepreneurship 
Database covers all new firms founded between1995 and 2001 and includes data on the entrepreneurs 
of each new registered business. 
 
The authors study the use of psychotropics among first time entrepreneurs who entered private sector 
entrepreneurship in the period from 1999 to 2001. The authors use a differences in differences 
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approach and match the 12,412 entrepreneurs with the closest (most similar) four individuals in the 
Danish population based on age, gender, home region, previous industry of employment (4-digit), 
wage (t-1), occupation level in the previous year, and education level. This gives us a matched sample 
of a total of 62,060 individuals.  
 
The same approach was used to study the use of psychotropics among spouses of entrepreneurs. 
Spouses were matched with the four closest spouses in the population based on age, gender, home 
region, wage in the previous year, and education level. The authors matched 5,007 spouses (of the 
12,412 above entrepreneurs) with 20,028 controls leaving us with a dataset of 25,035 individuals. 
 
In both studies, the authors draw the controls from the pool of individuals who changed their job in the 
same period. This ensures that the authors do not capture effects associated with change in jobs in 
general, but the effects from entering entrepreneurship, more specifically. Also, both samples are 
limited to entrepreneurs and spouses who have not been entrepreneurs in the past and/or received 
pscyhotropics in the year before the founding. The aim is to see the effect of entering into 
entrepreneurship for the first time. Serial entrepreneurs were excluded because they are less likely to 
be affected by the transition. Persons receiving psychotropics the year before entering 
entrepreneurship were also excluded in order to eliminate confounding illness from prescription of the 
medication. 
 
Measures 
Drug types are classified according to the Anatomical Therapeutic Chemical (ATC) classification 
system which is maintained by the World Health Organization Collaborating Centre for Drug 
Statistics Methodology in Oslo, Norway. This database enables us to select the medication (by ATC-
codes) which is typically associated with symptoms of occupational stress. 
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The following psychotropics were chosen: Benzodiazepines, benzodiazepine derivative (ATC: N05CF 
and N05BA, respectively) and antidepressants of the type selective serotonin reuptake inhibitors 
(SSRI) (ATC: N06AB).  
 
Based on these types of medication, the authors choose the relevant prescriptions and create two 
dependent variables. A binary measure for whether the individual has received any medication (or not) 
within the calendar year, and a continuous measure for the total number of daily doses of these 
medication that each individual have received within the calendar year. The authors look at the stress-
related medication together and separately. 
 
Statistical analysis 
Our sample is a matched case-control sample with four controls for each case. The authors use the 
statistical software STATA (Version 10) for sampling and analysis. The authors run logistic 
regressions with fixed effects (using the xtlogit procedure) on the sample groups, each consisting of 
one entrepreneur and four similar non-entrepreneurs. This enables us statistically to control for 
unobserved heterogeneity within sample groups which further isolates the entrepreneurship related 
difference within each group and strengthens the estimates. The authors should note that fixed effects 
regressions will not include sample groups, which do not have any variation on stress. Accordingly, 
the regressions only include sample groups with one or more prescriptions and not the groups where 
all or none of the group members get prescriptions. 
 
RESULTS 
Stress of entrepreneurs 
Descriptive statistics for the analyzed population are shown in Table 1. The matched samples are 
closely related. The average age of entrepreneurs and their controls are 34 years and 74.8% of them 
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are male. The spouses of entrepreneurs and their controls are 35 years on average and 24.5% of them 
are male. 
 
Table 1: Descriptive Statistics for the Analyzed Population 
  Entrepreneurs Controls Spouses Controls 
  Mean SD Mean SD Mean SD Mean SD 
         
Age (years) 34.0 9.8 34.1 9.8 35.2 9.1 35.2 9.1 
Men (percentage) 74.8% 0.4 74.8% 0.4 24.5% 0.4 24.5% 0.4 
Relationship 
(percentage) 66.8% 0.5 63.6% 0.5 100.0%  100.0%  
No. of pre-school 
children 0.3 0.4 0.3 0.5 0.4 0.5 0.4 0.5 
No. of school children 0.2 0.4 0.2 0.4 0.3 0.5 0.3 0.5 
         
No. of employees 1.2 0.4     1.3 0.5     
         
N 12,412   49,648   5,007   20,028   
 
The authors examine the risk of receiving antidepressants, hypnotics and anxiolytics within the first 
year after founding a firm (Table 2). Two key variables are emphasized. First, a dummy variable (0,1) 
indicates for each individual whether it is an entrepreneur (=1). Second, the (naturally logged) number 
of employees in their business is added. With both variables in the same specification, the 
entrepreneur dummy variable represents the entrepreneurs with no employees besides themselves. The 
second variable represents the entrepreneurs with more than one employee. It is important to note that 
90% of the entrepreneurs (11,167 individuals) belong to the first group of entrepreneurs with no 
employees in the first year. 
 
Table 2: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Entrepreneur 0.97 0.79-1.18 0.750  0.98 0.76-1.26 0.881 
Size of business (logged) 1.14 0.79-1.66 0.478  1.28 0.88-1.87 0.204 
        
Relationship 0.62 0.51-0.75 0.000  0.82 0.67-1.00 0.045 
Pre-school children 0.74 0.57-0.94 0.015  0.77 0.60-0.97 0.030 
School children 1.09 0.86-1.38 0.466   1.15 0.91-1.45 0.232 
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The authors find that entrepreneurs are significantly more likely to receive antidepressants (SSRI) in 
the first year if they run the firms themselves without employees. These entrepreneurs are 23% (odds 
ratio 1.23 [95% CI: 1.07-1.46], P=0.024) more likely than non-entrepreneurs to receive 
antidepressants. In the same specification, the authors further find a significant decreasing effect for 
entrepreneurs starting larger companies (0.41 [95% CI: 0.23-0.75], P=0.024). This shows that even 
though entrepreneurs are generally more likely to get stress, the likelihood is smaller for entrepreneurs 
running larger firm. There are no significant differences between entrepreneurs and their controls for 
hypnotics and anxiolytics. 
 
Table 3: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Male Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Entrepreneur 1.47 0.81-1.34 0.768  1.41 1.13-1.76 0.002 
Size of business (logged) 0.94 0.58-1.51 0.795  0.37 0.17-0.81 0.013 
        
Relationship 0.59 0.45-0.77 0.000  0.61 0.47-0.79 0.000 
Pre-school children 0.86 0.63-1.18 0.343  0.96 0.72-1.28 0.800 
School children 1.11 0.82-1.49 0.504   0.93 0.69-1.23 0.602 
 
The authors investigate this finding further by dividing our sample of entrepreneurs and their controls 
into male and female entrepreneurs (Table 3 and 4, respectively). The authors find that male 
entrepreneurs are more likely to receive antidepressants in the first year compared to their male control 
groups if they start without employees (1.41 [95% CI: 1.13-1.76], P=0.002). In addition, the authors 
find that entrepreneurs with larger companies are less likely to get stress (0.37 [95% CI: 0.17-0.81], 
P=0.013). 
 
There are no significant differences between female entrepreneurs and their control group for 
antidepressants. Also, there are generally no differences between entrepreneurs of any gender and their 
control groups for hypnotics and anxiolytics. The authors have investigated all these effects for the 
second year and find no significant relationships between the use of this medication and becoming an 
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entrepreneur. However, entrepreneurs already treated with psychotropics in the first year have a high 
likelihood of also being on the medication in the second year (177.20 [95% CI: 123.05-255.19], 
P=0.0001). 
 
Table 4: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Female Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Entrepreneur 0.85 0.61-1.19 0.343  0.97 0.72-1.31 0.838 
Size of business (logged) 1.71 0.90-3.28 0.103  0.48 0.19-1.20 0.118 
        
Relationship 0.63 0.47-0.85 0.002  0.79 0.60-1.05 0.108 
Pre-school children 0.56 0.37-0.85 0.007  0.78 0.55-1.09 0.143 
School children 1.06 0.73-1.56 0.745   1.18 0.84-1.65 0.345 
 
Stress of entrepreneurs' spouses 
It is clear that the health of entrepreneurs is affected by the decision to enter entrepreneurship. The 
decision increases the likelihood of depression by about 23% compared to similar individuals if they 
found a company alone. The authors investigate how entry into entrepreneurship affects the spouses of 
individuals making the transition. 
  
Table 5: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Spouses of Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Spouse of entrepreneur 1.40 1.04.1.86 0.024  1.40 1.06-1.85 0.019 
Size of business (logged) 0.86 0.50-1.49 0.593  0.60 0.34-1.07 0.081 
        
Pre-school children 0.63 0.43-0.91 0.015  0.79 0.57-1.08 0.135 
School children 0.70 0.50-0.98 0.040   0.94 0.69-1.27 0.682 
 
The likelihood that spouses suffer from their husbands or wives becoming entrepreneurs is reported in 
Table 5. In the first year, the authors find that spouses of entrepreneurs (starting businesses on their 
own) are 40% more likely to get hypnotics and anxiolytics (1.40 [95% CI: 1.04-1.86], P=0.024) and 
antidepressants (1.40 [95% CI: 1.06-1.85], P=0.019) compared to spouses of non-entrepreneurs. The 
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authors only find a significant reducing effect for entrepreneurs with larger businesses when looking at 
antidepressants (0.60 [95% CI: 0.34-1.07], P=0.081). The effects fade off in the second year where 
there are not any difference between spouses of entrepreneurs and spouses of non-entrepreneurs. 
 
The authors further investigate these findings on spouses by dividing the sample into male and female 
spouses and repeating the analysis (Table 6 and 7, respectively). The authors find that female spouses 
of entrepreneurs (with no employees) are 33 and 45% more likely to receive hypnotics/anxiolytics 
(1.33 [95% CI: 0.96-1.85], P=0.085) and antidepressants (1.23 [95% CI: 1.07-1.97], P=0.017), 
respectively. In addition, spouses of entrepreneurs are less likely to receive antidepressants (0.47 [95% 
CI: 0.23-0.96], P=0.038) if their partner founds a company with employees. 
 
Table 6: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Male Spouses of 
Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Spouse of entrepreneur 1.69 0.90-3.16 0.101  1.18 0.57-2.41 0.659 
Size of business (logged) 1.71 0.65-4.48 0.275  1.38 0.46-4.14 0.569 
        
Pre-school children 0.96 0.45-2.03 0.916  0.60 0.27-1.38 0.228 
School children 0.84 0.41-1.72 0.632   1.05 0.51-2.19 0.892 
 
Table 7: Fixed Effects Logistic Regression Predicting Prescription of Psychotics for Female Spouses of 
Entrepreneurs 
  Hypnotics/anxiolytics   Antidepressants (SSRI) 
  
Odds 
ratio 95% CI P   
Odds 
ratio 95% CI P 
        
Spouse of entrepreneur 1.33 0.96-1.85 0.085  1.45 1.07-1.97 0.017 
Size of business (logged) 0.61 0.28-1.30 0.202  0.47 0.23-0.96 0.038 
        
Pre-school children 0.53 0.35-0.83 0.005  0.82 0.58-1.15 0.251 
School children 0.69 0.47-1.01 0.056   0.91 0.64-1.27 0.567 
 
There is no significant difference between male spouses of entrepreneurs and their respective controls. 
This is likely to be due to the smaller sample of male spouses. The magnitude of the estimates for 
males on hypnotics/anxiolytics is higher than for females, which would indicate that significant and 
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stronger effects could be possible with a larger sample of male spouses. In all specifications, there are 
no differences on the second year effects. 
 
DISCUSSION 
This is the first study with a large sample size investigating the direct effect of entering 
entrepreneurship on prescription of psychotropics. The major finding of this study is that 
entrepreneurs founding businesses alone are more likely to receive psychotropics than persons 
changing to another job. Spouses of these entrepreneurs have an even higher risk of receiving 
psychotropics than matched controls. These results suggest that entering entrepreneurship has a 
significant effect on the health of not only entrepreneurs but also their spouses.  
 
Mean age was 34 and 75 % of the entrepreneurs were males and this is consistent with other studies 
(1;17;18). Entrepreneurs were more likely to receive antidepressants whereas spouses of entrepreneurs 
more often received both hypnotics and antidepressants. Antidepressant medication has several 
indications, e.g. depression, anxiety and obsessive-compulsive disorder and since no data on 
indication were available, it is not possible to relate the increased use to any particular symptoms or 
disease (19). However, antidepressants do not have indications for stress or the less severe forms of 
depression which might be the most likely diagnosis in most of these cases. Also the benzodiazepines 
have several indications, e.g. anxiety and insomnia (20). Furthermore, the limitation of registers 
should also be noticed. Even though the medication is prescribed, there are no guarantees that patients 
actually take the medication. In extreme cases, they might even pass it on to family members or sell it 
(21;22).  
 
The increased use of antidepressants and hypnotics was most profound the first year after entering 
entrepreneurship and declined the second year. This might be due to adaptation to being an 
entrepreneur for those who succeed. However, the authors also found that entrepreneurs receiving 
antidepressants in the first years were also extremely likely to do so in year two. This might suggest 
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that entering entrepreneurship is a long-term stress condition. Alternatively, it can be explained by 
treatment principles, e.g. medication is not discontinued within the first year. 
 
Even though the time from registering a company until the first prescription is rather short in this 
study, it is worth emphasizing that the efforts to start up firms begin long before the registration date 
(23) . Planning and registering an entry into entrepreneurship is a complicated and resource consuming 
process, which is initiated long before the registration date. This suggests that the build-up of stress 
might have been going on for some time when the firm is registered.   
 
The generalizability of these findings is unclear and generalization should only be done with caution 
because of differences in guidance of entrepreneurs and health care systems between countries. In 
some countries entering entrepreneurship leads to loss of health insurance which complicates 
generalization. In Denmark, all inhabitants have public health insurance and therefore the results show 
the more direct effect of entering entrepreneurship. 
  
Since this study is observational, the authors cannot make any clear explanation for the increased use 
of psychotropics among entrepreneurs and their spouses. The prevalence of mental problems among 
the study population might be underestimated because entrepreneurs might be less prone to seek 
medical help due to an increased workload and stress (24). Furthermore, use of over-the-counter stress 
related medications, consumption of alcohol or illicit drugs were not included in the study.  
 
Female entrepreneurs seem to have a lower risk of receiving psychotropics, and this might be 
explained by the fact that females tend to have a less financial risk taking behavior, or they simply 
might start different type of business than male entrepreneurs (25;26).   
 
The authors find stronger effects for spouses than for entrepreneurs. It has previously been found that 
lack of control over a situation, which has large consequences for a person without control, can lead to 
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health problems (27;28). Spouses are affected by the decision to enter entrepreneurship, but have 
limited control and information about the situation. This could explain the larger effect on spouses. 
 
The authors find that the number of employees in the business has a reducing effect on the likelihood 
of medication for entrepreneurs. Larger number of employees in the first years is often viewed as an 
indicator of success and lowers the risk of failure for the entrepreneur (7). The more employees the 
entrepreneur has in the first year, the lower the risk of stress and the lower the risk of firm failure. 
 
These findings should lead to more focus on the mental health of new entrepreneurs and their spouses. 
Further, improved guidance on how to enter entrepreneurship and manage the challenges during the 
first years might be beneficial for entrepreneurs, the spouses, and also the survival rate of the 
company. Mental problems of this sort are likely also to hurt the entrepreneurs’ abilities to run their 
business. 
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